Search results
AstraZeneca Aims for $80 Billion in Sales by 2030
Bloomberg· 20 hours agoHave a confidential tip for our reporters? AstraZeneca Plc aims to almost double sales to $80 billion by 2030 as Chief Executive Officer Pascal Soriot...
AstraZeneca’s fasenra asthma drug shows promise for COPD treatment
BioPharma-Reporter· 14 hours agoThis approval extends Fasenra's availability to over 80 countries, including the US, EU, and Japan....
Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
Benzinga· 1 day agoA Delaware federal jury has determined that AstraZeneca Plc AZN must pay Pfizer Inc PFE $107.5...
AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post...
Benzinga· 20 hours agoToday AstraZeneca revealed its bold ambition to deliver $80 billion in Total Revenue by 2030, up from $45.8 billion in 2023. This will be achieved through significant growth ...
From In-House at AstraZeneca to an E-discovery Startup: New Fileread GC Discusses Major Career Move...
Law.com· 1 day agoThe fast evolution of artificial intelligence is spurring a new generation of legal tech...
AstraZeneca kicks off ‘new era of growth’ with $80 billion sales goal by 2030
Market Watch· 18 hours agoThe Anglo-Swedish pharmaceutical company’s CEO Pascal Soriot said the announcement marks the start...
FTSE 100 Live 21 May: Inflation in focus after index closes slightly down
Evening Standard via Yahoo Finance· 6 hours agoThe FTSE 100 is close to where it started the day, despite losing almost 50 points in early trading....
AstraZeneca Targets $80B Revenue by 2030 Through Pipeline Expansion
Market Watch· 20 hours agoBy Helena Smolak AstraZeneca has set out a target to grow revenue to $80 billion by 2030 as it aims to bolster its investment in technologies and platforms....
Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient...
Benzinga via Yahoo Finance· 1 day agoSunday, Amgen Inc (NASDAQ:AMGN) and AstraZeneca Plc (NASDAQ:AZN) announced the results of the Phase...
Analyst Report: AstraZeneca PLC
Morningstar Research via Yahoo Finance· 6 hours agoA merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, ...